Literature DB >> 45600

Abortive growth of human lymphocytes carrying a dormant Epstein-Barr viral genome.

T Aya1, T Osato.   

Abstract

When P3HR-1 lymphoblastoid cells expressing Epstein-Barr virus (EBV)-related antigens at very low frequency were cocultivated with human umbilical cord blood lymphocytes and the cell-free mixed culture fluid was applied to fresh cord lymphocytes, cells morphologically distinct from normal lymphocytes became evident after one to two weeks' exposure. The abnormal cells became abundant after one month and were easily identified by B-cell markers and a variety of morphologic abnormalities. Such abnormal B-lymphocytes appeared to be negative for EBV-determined nuclear antigen (EBNA), but when the immunofluorescence-negative cells were exposed to pokeweed mitogen and 5-iododeoxyuridine, a striking EBNA induction occurred. The growth of these abnormal cells was limited and they could be maintained for no more than three months. The implications of these findings are discussed in relation to the biological activity of EBV.

Entities:  

Mesh:

Year:  1978        PMID: 45600     DOI: 10.1007/bf02125494

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  37 in total

1.  Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.

Authors:  K O Fresen; H Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

2.  Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes).

Authors:  P Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

3.  Epstein-Barr virus in human lymphoblastoid cells: enhancing the percentage of virus-positive cells by cocultivation with African green monkey (Vero) cells.

Authors:  B Hampar; L M Martos; J L Walker
Journal:  J Natl Cancer Inst       Date:  1971-09       Impact factor: 13.506

4.  Host cell macromolecular synthesis in cells containing EBV-induced early antigens, studied by combined immunofluorescence and radioautography.

Authors:  L Gergely; G Klein; I Ernberg
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

Review 6.  Various forms of Epstein-Barr virus infection in man: established facts and a general concept.

Authors:  M A Epstein; B G Achong
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

7.  Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus.

Authors:  J H Pope
Journal:  Aust J Exp Biol Med Sci       Date:  1968-10

8.  Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation.

Authors:  U Schneider; H zur Hausen
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

9.  Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.

Authors:  M S Hirsch; S M Phillips; C Solnik; P H Black; R S Schwartz; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  1 in total

1.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.

Authors:  K Takada; T Osato
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.